Latest News

Coca-Cola and Altria are worth buying, but PepsiCo faces more formidable challenges.

Oracle's force majeure notice on its Project Jupiter AI data center, tied to a natural gas pipeline delay, raises risk questions for Oracle, Bloom Energy, and Energy Transfer, though analysts remain bullish.

Interactive Brokers is benefiting from increased risk-taking, which could quickly end if a bear market develops.

Given the quantum computing company's high and speculative valuation, its stock returns will depend heavily on how it fares on its path toward commercialization.

Goldman Sachs sounds a warning on AI hyperscaler profits.

An increasing number of headwinds could make the S&P 500 vulnerable to a steep correction.

Greater longevity, healthcare expenses, inflation, and unexpected costs are likely to expand your investment needs.

One may have higher upside, but the downside is also much higher.

Verisk Analytics (NASDAQ:VRSK) CFO Elizabeth Mann said the company continues to target 6% to 8% annual organic constant-currency revenue growth despite recent pressure from unusually light weather-related claims activity and a normalization in insurance premium growth. Speaking at an investor event

BioPharma Credit (LON:BPCP) reported a higher share price and continued portfolio diversification in its half-year investor presentation, while manager Pharmakon said it is managing cash to support new lending opportunities and potential future repayments. Pedro Gonzalez de Cosio, chief executive o

Diamondback Energy shares fell after a Morgan Stanley downgrade and a large share block sale, but strong Q2 earnings and a persistent Middle East supply gap support a higher oil price floor.

The $2,000 figure sounds outrageous -- until you consider what Micron is earning today. But there's a catch.

Two better opportunities might be sitting right next to this stock, and it's forcing a real decision about whether to keep holding.

Ford has a complicated history with its dividend but has now paid investors consistently since 2022.

A $14,000 TFSA can generate over $896 in annual passive income with three reliable dividend stocks. Here's how I'd structure it.

Financial planning can involve many different considerations, particularly when an individual or family has significant assets or outstanding tax obligatio

Buying a house involves much more than choosing a location or liking the interior design. A Home Inspection Service provides a closer look at the accessibl

BlackBerry secured a $100 million-plus QNX software deal with Coretura, the Daimler Truck-Volvo joint venture, validating its Alloy Kore platform ahead of second-quarter earnings on Sept. 24.

Finding an ent specialist in lahore becomes important when recurring ear, nose, or throat symptoms start affecting your comfort and routine. From persisten

It's too good a value to pass up on right now.

Picking stocks for the next decade requires a different lens than picking for the next earnings report, and these 3 names pass the test.

Sandisk can still make investors richer despite multiplying exponentially over the past year and a half.

Cytokinetics (NASDAQ:CYTK) executives outlined the company’s commercial expansion plans, cardiovascular pipeline and business-development priorities during a Bernstein investor symposium, highlighting the launch of MYQORZO and clinical programs targeting several forms of heart failure. Isaac Ciecha

Ferrellgas Partners (OTCMKTS:FGPR) reported fourth-quarter adjusted EBITDA of $23.8 million, up 3% from the prior-year period, while full-year fiscal 2026 adjusted EBITDA declined 3% to $321.3 million as warmer weather reduced propane demand and the company resolved legacy liability claims. Preside

Hyperscaler stocks could rebound in 2027, according to a Goldman Sachs scenario for capital spending, revenue growth and free cash flow.